The Opioid Crisis: a Comprehensive Overview

  • Nalini Vadivelu
  • Alice M. Kai
  • Vijay Kodumudi
  • Julie Sramcik
  • Alan D. Kaye
Other Pain (A Kaye and N Vadivelu, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Other Pain

Abstract

Purpose of Review

The opioid crisis most likely is the most profound public health crisis our nation has faced. In 2015 alone, 52,000 people died of drug overdoses, with over 30,000 of those people dying from opioid drugs. A recent community forum led by the Cleveland Clinic contrasted this yearly death rate with the loss of 58,000 American lives in 4 years of the Vietnam War. The present review describes the origins of this opioid epidemic and provides context for our present circumstances.

Recent Findings

Alarmingly, the overwhelming majority of opioid abusers begin their addiction with prescription medications, primarily for chronic pain. Chronic postoperative pain, which occurs in 10–50% of surgical patients, is a major concern in many types of surgery. Nationwide, the medical community has made it a priority to ensure that postsurgical analgesia is sufficient to control pain without increasing non-medically appropriate opioid use.

Summary

The opioid epidemic remains a significant pressing issue and will not resolve easily. Numerous factors, including the inappropriate prescription of opioids, lack of understanding of the potential adverse effects of long-term therapy, opioid misuse, abuse, and dependence, have contributed to the current crisis.

Keywords

Opioids Overdose deaths Pain Health policy 

Notes

Compliance with Ethical Standards

Conflict of Interest

Nalini Vadivelu, Alice M. Kai, Vijay Kodumudi, and Julie Sramcik declare no conflict of interest. Dr. Kaye is a speaker for Depomed, Inc., and Merck, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    • Rudd RA. Increases in Drug and Opioid-Involved Overdose Deaths—United States, 2010–2015. MMWR Morbidity and Mortality Weekly Report. 2016;65. Death count report of opioid-related overdose deaths.Google Scholar
  2. 2.
    Rudd RA, Aleshire N, Zibbell JE, Matthew Gladden R. Increases in drug and opioid overdose deaths—United States, 2000–2014. Am J Transplant. 2016;16(4):1323–7.  https://doi.org/10.1111/ajt.13776.CrossRefGoogle Scholar
  3. 3.
    Jones CM. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths—United States, 2002–2014. MMWR Morbidity and Mortality Weekly Report. 2016;65.Google Scholar
  4. 4.
    Gladden RM. Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths—27 states, 2013–2014. MMWR Morbidity and Mortality Weekly Report. 2016;65.Google Scholar
  5. 5.
    Peterson AB. Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013–2015. MMWR Morbidity and Mortality Weekly Report. 2016;65.Google Scholar
  6. 6.
    Clarke JL, Skoufalos A, Scranton R. The American opioid epidemic: population health implications and potential solutions. Report from the National Stakeholder Panel. Popul Health Manag. 2016;19(S1):S-1–S-10.CrossRefGoogle Scholar
  7. 7.
    Policy SLoD. Harrison Narcotics Tax Act, 1914 [May 14, 2017]. Available from: http://www.druglibrary.org/schaffer/history/e1910/harrisonact.htm.
  8. 8.
    Weiner SG, Malek SK, Price CN. The opioid crisis and its consequences. Transplantation. 2017;101(4):678–81.  https://doi.org/10.1097/TP.0000000000001671.CrossRefPubMedGoogle Scholar
  9. 9.
    Declaration of Montreal 2010. (2017). Available from: http://www.iasp-pain.org/DeclarationofMontreal?
  10. 10.
    Meier B. Pain killer: A" wonder" drug's trail of addiction and death: Rodale; 2003.Google Scholar
  11. 11.
    Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25(2):171–86.  https://doi.org/10.1016/0304-3959(86)90091-6.CrossRefPubMedGoogle Scholar
  12. 12.
    Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7.  https://doi.org/10.2105/AJPH.2007.131714.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Control CfD, Prevention. CDC grand rounds: prescription drug overdoses—a US epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10.Google Scholar
  14. 14.
    Lipton B CD, Robertson J. Workers Compensation prescription drug study: 2013 update. September 2013 [May 14, 2017]. Available from: https://www.ncci.com/Articles/Documents/II_Prescription_Drugs-2013.pdf.
  15. 15.
    Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009;10(12):1187–204.  https://doi.org/10.1016/j.jpain.2009.10.002.CrossRefPubMedGoogle Scholar
  16. 16.
    Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med. 2006;9(6):1454–73.  https://doi.org/10.1089/jpm.2006.9.1454.CrossRefPubMedGoogle Scholar
  17. 17.
    Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med. 2012;13(2):150–74.  https://doi.org/10.1111/j.1526-4637.2011.01310.x.CrossRefPubMedGoogle Scholar
  18. 18.
    Hwang U, Belland LK, Handel DA, Yadav K, Heard K, Rivera-Reyes L, et al. Is all pain is treated equally? A multicenter evaluation of acute pain care by age. Pain. 2014;155(12):2568–74.  https://doi.org/10.1016/j.pain.2014.09.017.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Society AP. Principles of analgesic use in the treatment of acute pain and cancer pain: American Pain Society; 1999.Google Scholar
  20. 20.
    Frasco PE, Sprung J, Trentman TL. The impact of the joint commission for accreditation of healthcare organizations pain initiative on perioperative opiate consumption and recovery room length of stay. Anesth Analg. 2005;100(1):162–8.  https://doi.org/10.1213/01.ANE.0000139354.26208.1C.CrossRefPubMedGoogle Scholar
  21. 21.
    Rodgers J, Cunningham K, Fitzgerald K, Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg. 2012;37(4):645–50.  https://doi.org/10.1016/j.jhsa.2012.01.035.CrossRefGoogle Scholar
  22. 22.
    • Macintyre P, Huxtable C, Flint S, Dobbin M. Costs and consequences: a review of discharge opioid prescribing for ongoing management of acute pain. Anaesth Intensive Care. 2014;42(5):558–74. The consequences of opioid pain regimens for pain therapy.PubMedGoogle Scholar
  23. 23.
    Martin PR, Finlayson AR. Opioid use disorder during pregnancy in Tennessee: expediency vs. science. Am J Drug Alcohol Abuse. 2015;41(5):367–70.  https://doi.org/10.3109/00952990.2015.1047502.CrossRefPubMedGoogle Scholar
  24. 24.
    Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821–6.  https://doi.org/10.1001/jamapsychiatry.2014.366.CrossRefPubMedGoogle Scholar
  25. 25.
    Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(2 Suppl):S63–88.PubMedGoogle Scholar
  26. 26.
    Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605–12.  https://doi.org/10.1097/AJP.0000000000000011.PubMedGoogle Scholar
  27. 27.
    Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–7.  https://doi.org/10.1001/jama.2012.234.CrossRefPubMedGoogle Scholar
  28. 28.
    Veliz P, Epstein-Ngo QM, Meier E, Ross-Durow PL, McCabe SE, Boyd CJ. Painfully obvious: a longitudinal examination of medical use and misuse of opioid medication among adolescent sports participants. J Adolesc Health. 2014;54(3):333–40.  https://doi.org/10.1016/j.jadohealth.2013.09.002.CrossRefPubMedGoogle Scholar
  29. 29.
    Krans EE, Patrick SW. Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic. Obstet Gynecol. 2016;128(1):4–10.  https://doi.org/10.1097/AOG.0000000000001446.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    • Psaty BM, Merrill JO. Addressing the opioid epidemic—opportunities in the postmarketing setting. N Engl J Med. 2017;2017(376):1502–4. A review of the evolvement of the public policy surrounding opioid use and how it has shaped pain management.CrossRefGoogle Scholar
  31. 31.
    Gan TJ, Robinson SB, Oderda GM, Scranton R, Pepin J, Ramamoorthy S. Impact of postsurgical opioid use and ileus on economic outcomes in gastrointestinal surgeries. Curr Med Res Opin. 2015;31(4):677–86.  https://doi.org/10.1185/03007995.2015.1005833.CrossRefPubMedGoogle Scholar
  32. 32.
    Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013;27(1):62–70.  https://doi.org/10.3109/15360288.2012.751956.CrossRefPubMedGoogle Scholar
  33. 33.
    Kessler ER, Shah M, Gruschkus KS, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacother J Hum Pharmacol Drug Ther. 2013;33(4):383–91.  https://doi.org/10.1002/phar.1223.CrossRefGoogle Scholar
  34. 34.
    Krashin D, Murinova N, Sullivan M. Challenges to treatment of chronic pain and addiction during the “opioid crisis”. Curr Pain Headache Rep. 2016;20(12):65.  https://doi.org/10.1007/s11916-016-0596-2.CrossRefPubMedGoogle Scholar
  35. 35.
    Martin BC, Fan M-Y, Edlund MJ, DeVries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26(12):1450–7.  https://doi.org/10.1007/s11606-011-1771-0.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, et al. Opioid prescription claims among women of reproductive age—United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64(2):37–41.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002.  https://doi.org/10.1097/AOG.0000000000000208.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Martin CE, Longinaker N, Terplan M. Recent trends in treatment admissions for prescription opioid abuse during pregnancy. J Subst Abus Treat. 2015;48(1):37–42.  https://doi.org/10.1016/j.jsat.2014.07.007.CrossRefGoogle Scholar
  39. 39.
    Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842–50.  https://doi.org/10.1542/peds.2014-3299.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):650–5.  https://doi.org/10.1038/jp.2015.36.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    • Murthy VH. Ending the opioid epidemic—a call to action. N Engl J Med. 2016;375(25):2413–5.  https://doi.org/10.1056/NEJMp1612578. An appeal by the Office of the Surgeon General to the medical community to aid in America’s escalating opioid epidemic.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Nalini Vadivelu
    • 1
  • Alice M. Kai
    • 2
  • Vijay Kodumudi
    • 3
  • Julie Sramcik
    • 1
  • Alan D. Kaye
    • 4
  1. 1.Department of AnesthesiologyYale UniversityNew HavenUSA
  2. 2.Department of Internal MedicineNYU Winthrop HospitalMineolaUSA
  3. 3.Medical StudentUniversity of Connecticut School of MedicineFarmingtonUSA
  4. 4.Department of AnesthesiologyLouisiana State University Health Sciences CenterNew OrleansUSA

Personalised recommendations